Article
ELISL: Early-Late Integrated Synthetic Lethality Prediction in Cancer
2022-09-19
Abstract excerpt
Anti-cancer therapies based on synthetic lethality (SL) exploit tumor vulnerabilities for treatment with reduced side effects. Since simultaneous loss-of-function of SL genes causes cell death, tumors with known gene disruptions can be treated by targeting SL partners. Computational selection of promising SL candidates amongst all gene combinations is key to expedite experimental screening. However, current SL pre...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a35d7faa-13b8-5212-b510-235bfca26c4c
- DOI
- 10.1101/2022.09.19.508413
